menu
    • menu

    Company profile for Armata Pharmaceuticals

    NEW Drugs in Dev: 6
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common infections can be serious or life-threatening. Additionally, the use of broad-spectr...
    Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common infections can be serious or life-threatening. Additionally, the use of broad-spectrum antibiotics is known for disrupting the ecology of the human microbiome, leading to disease. To combat the rapidly growing global problem of drug-resistant bacterial infections

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Armata PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4503 Glencoe Avenue Marina del Rey, CA 90292
    Telephone
    Telephone
    +1 (310) 665-2928
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.armatapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ELCC

    ELCC

    Not Confirmed

    envelop Contact Supplier

    ELCC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Armata Pharma Reveals 2025 Financial Performance
    Armata Pharma Reveals 2025 Financial Performance

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-fourth-quarter-and-full-year-2025-financial-results-302725089.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    Armata Pharma Gets FDA (QIDP) Designation For AP-SA02
    Armata Pharma Gets FDA (QIDP) Designation For AP-SA02

    23 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armata-pharmaceuticals-receives-fda-qualified-infectious-disease-product-qidp-designation-for-ap-sa02-302694147.html

    PR NEWSWIRE
    23 Feb 2026
    Share Share
    Armata Pharma Advances AP-SA02 to Phase 3 for S. aureus
    Armata Pharma Advances AP-SA02 to Phase 3 for S. aureus

    13 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-end-of-phase-2-meeting-with-fda-and-plans-to-advance-ap-sa02-to-a-phase-3-superiority-study-in-complicated-bacteremiastaphylococcusaureus-302659583.html

    PR NEWSWIRE
    13 Jan 2026
    Share Share
    Armata Pharma Hosts KOL Webinar On S. Aureus Bacteremia & AP-SA02
    Armata Pharma Hosts KOL Webinar On S. Aureus Bacteremia & AP-SA02

    18 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-key-opinion-leader-webinar-on-s-aureus-bacteremia-and-ap-sa02-hosted-by-jones-research-on-november-25th-at-1000am-est-302618023.html

    PR NEWSWIRE
    18 Nov 2025
    Share Share
    Armata Pharma Reveals Q3 2025 Results & Corporate Update
    Armata Pharma Reveals Q3 2025 Results & Corporate Update

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-third-quarter-2025-results-and-provides-corporate-update-302613100.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Armata Pharma Commissions cGMP Phage Facility In Los Angeles
    Armata Pharma Commissions cGMP Phage Facility In Los Angeles

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-formal-commissioning-of-state-of-the-art-cgmp-phage-manufacturing-facility-in-los-angeles-california-302607412.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search